Last Price
273.30
Today's Change
-5.15 (1.84%)
Day's Change
272.37 - 275.24
Trading Volume
713,845
Market Cap
132 Billion
Shares Outstanding
483 Million
Avg Volume
724,103
Avg Price (50 Days)
281.36
Avg Price (200 Days)
270.95
PE Ratio
34.86
EPS
7.84
Earnings Announcement
13-Feb-2024
Previous Close
278.45
Open
275.10
Day's Range
272.37 - 275.24
Year Range
228.65 - 312.99
Trading Volume
713,845
1 Day Change
-1.85%
5 Day Change
0.20%
1 Month Change
-5.08%
3 Month Change
-6.81%
6 Month Change
16.75%
Ytd Change
-5.20%
1 Year Change
-9.08%
3 Year Change
0.84%
5 Year Change
37.93%
10 Year Change
302.21%
Max Change
32947.16%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.